The relationship between the responses to prior systemic therapies and the efficacy of subsequent pemetrexed (Pem) therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Sun, J. [1 ,2 ]
Oh, D. [1 ,2 ]
Lee, S. [1 ,2 ]
Kim, D. [1 ,2 ]
Im, S. [1 ,2 ]
Kim, T. [1 ,2 ]
Lee, J. [1 ,2 ]
Kim, Y. [1 ,2 ]
Heo, D. S. [1 ,2 ]
Bang, Y. [1 ,2 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Bundang Hosp, Seoul 110744, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8061
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Meta-Analysis Examining Impact of Age on Pemetrexed (pem) Efficacy for the Treatment of Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC)
    Paz-Ares, L. G.
    Zimmermann, A.
    Ciuleanu, T. E.
    Bunn, P. A.
    San Antonio, B.
    Denne, J.
    Iturria, N.
    John, W.
    Scagliotti, G. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S43 - S43
  • [22] Meta-analysis examining impact of age on pemetrexed (pem) efficacy for the treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC).
    Paz-Ares, Luis
    Zimmermann, Annamaria
    Ciuleanu, Tudor-Eliade
    Bunn, Paul A.
    San Antonio, Behan
    Denne, Jonathan
    Iturria, Nancy
    John, William J.
    Vittorio Scagliotti, Giorgio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study
    de Castro, J.
    Tagliaferri, P.
    de Lima, V. C. C.
    Ng, S.
    Thomas, M.
    Arunachalam, A.
    Cao, X.
    Kothari, S.
    Burke, T.
    Myeong, H.
    Grattan, A.
    Lee, D. H.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [24] EFFICACY AND SAFETY OF PEMETREXED AS SECOND-LINE TREATMENT IN ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE ANALYSIS
    Passaro, A.
    Pochesci, A.
    Palleschi, M.
    Pellegrino, A.
    Fabbri, M. A.
    Urbano, F.
    Gentile, V.
    Manai, C.
    Pavese, I.
    Cortesi, E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
  • [25] PEMETREXED MAINTENANCE THERAPY (PEM-MT) IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSQ-NSCLC): A PRACTICE PATTERN ANALYSIS
    Adam, V.
    Peeters, L.
    Dooms, C.
    Nackaerts, K.
    Lepers, S.
    Oyen, C.
    Vansteenkiste, J.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S46 - S46
  • [26] Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
    Cohen, Martin H.
    Cortazar, Patricia
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (12): : 1352 - 1358
  • [27] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
  • [28] Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
    Velez, Michel
    Arango, Belisario A.
    Perez, Cesar A.
    Santos, Edgardo S.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 117 - 124
  • [29] Tepotinib in patients (pts) with advanced non-small cell lung cancer (NSCLC) with MET amplification (METamp).
    Le, Xiuning
    Paz-Ares, Luis G.
    Van Meerbeeck, Jan
    Viteri, Santiago
    Galvez, Carlos Cabrera
    Baz, David Vicente
    Kim, Young-Chul
    Kang, Jin-Hyoung
    Schumacher, Karl-Maria
    Karachaliou, Niki
    Adrian, Svenja
    Bruns, Rolf
    Paik, Paul K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] ALK FISH positivity and crizotinib efficacy in patients (pts) with non-small cell lung cancer (NSCLC).
    Soria, Jean-Charles
    Ho, Steffan N.
    Varella-Garcia, Marileila
    Iafrate, A. John
    Solomon, Benjamin J.
    Shaw, Alice T.
    Blackhall, Fiona Helen
    Mok, Tony
    Wu, Yi-Long
    Pestova, Ekaterina
    Siebert, Fred W.
    Wilner, Keith D.
    Polli, Anna
    Paolini, Jolanda
    Lanzalone, Silvana
    Green, Stephanie J.
    Camidge, D. Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345